Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Oak Ridge Institute for Science and Education (ORISE), contracted to Division of Viral Diseases, Centers for Disease Control and Prevention, Oak Ridge, Tennessee, USA.
mSphere. 2020 Nov 18;5(6):e00840-20. doi: 10.1128/mSphere.00840-20.
Between 2015 and 2017, routine molecular surveillance in the United States detected multiple mumps viruses (MuVs) with mutations in the small hydrophobic (SH) gene compared to a reference virus of the same genotype. These mutations include an unusual pattern of uracil-to-cytosine hypermutations and other mutations resulting in the generation of premature stop codons or disruption of the canonical stop codon. The mumps virus SH protein may serve as a virulence factor, based on evidence that it inhibits apoptosis and innate immune signaling and that recombinant viruses that do not express the SH protein are attenuated in an animal model. In this study, mumps viruses bearing variant SH sequences were isolated from contemporary outbreak samples to evaluate the impact of the observed mutations on SH protein function. All isolates with variant SH sequences replicated in interferon-competent cells with no evidence of attenuation. Furthermore, all SH-variant viruses retained the ability to abrogate induction of NF-κB-mediated innate immune signaling in infected cells. Ectopic expression of variant mumps SH genes is consistent with findings from infection experiments, indicating that the observed abrogation of signaling was not mediated by other viral factors that may modulate innate immune signaling. Molecular surveillance is an important public health tool for monitoring the diversity of circulating mumps viruses and can provide insights into determinants of disease. These findings, in turn, will inform studies employing reverse genetics to elucidate the specific mechanisms of MuV pathogenesis and potential impacts of observed sequence variants on infectivity, fitness, and virulence. Mumps virus (MuV) outbreaks occur in the United States despite high coverage with measles, mumps, rubella (MMR) vaccine. Routine genotyping of laboratory-confirmed mumps cases has been practiced in the United States since 2006 to enhance mumps surveillance. This study reports the detection of unusual mutations in the small hydrophobic (SH) protein of contemporary laboratory-confirmed mumps cases and is the first to describe the impact of such mutations on SH protein function. These mutations are predicted to profoundly alter the amino acid sequence of the SH protein, which has been shown to antagonize host innate immune responses; however, they were neither associated with defects in virus replication nor attenuated protein function , consistent with detection in clinical specimens. A better understanding of the forces governing mumps virus sequence diversity and of the functional consequences of mutations in viral proteins is important for maintaining robust capacity for mumps detection and disease control.
2015 年至 2017 年期间,美国开展了常规的分子监测,发现了多种与同一基因型参考病毒相比,在小疏水(SH)基因中发生突变的腮腺炎病毒(MuV)。这些突变包括异常的尿嘧啶到胞嘧啶超突变模式以及其他导致提前终止密码子或破坏规范终止密码子的突变。基于腮腺炎病毒 SH 蛋白抑制细胞凋亡和先天免疫信号的证据,以及不表达 SH 蛋白的重组病毒在动物模型中减毒的证据,SH 蛋白可能是一种毒力因子。在这项研究中,从当代暴发样本中分离出了携带变异 SH 序列的腮腺炎病毒,以评估观察到的突变对 SH 蛋白功能的影响。所有具有变异 SH 序列的分离株都在干扰素功能正常的细胞中复制,没有证据表明其衰减。此外,所有 SH 变异病毒都保留了在感染细胞中阻断 NF-κB 介导的先天免疫信号诱导的能力。变异腮腺炎 SH 基因的异位表达与感染实验的结果一致,表明观察到的信号阻断不是由可能调节先天免疫信号的其他病毒因子介导的。分子监测是监测循环腮腺炎病毒多样性的重要公共卫生工具,可以为疾病的决定因素提供信息。反过来,这些发现将为采用反向遗传学研究阐明 MuV 发病机制的具体机制以及观察到的序列变异对感染性、适应性和毒力的潜在影响提供信息。尽管美国麻疹、腮腺炎、风疹(MMR)疫苗的接种率很高,但仍会发生腮腺炎病毒(MuV)暴发。自 2006 年以来,美国一直在对实验室确诊的腮腺炎病例进行常规基因分型,以加强腮腺炎监测。本研究报告了在当代实验室确诊的腮腺炎病例中发现了小疏水(SH)蛋白的异常突变,这是首次描述此类突变对 SH 蛋白功能的影响。这些突变预计会极大地改变 SH 蛋白的氨基酸序列,该序列已被证明能拮抗宿主先天免疫反应;然而,它们既与病毒复制缺陷无关,也与蛋白功能减弱无关,这与在临床标本中的检测结果一致。更好地了解影响腮腺炎病毒序列多样性的力量以及病毒蛋白突变的功能后果,对于保持腮腺炎检测和疾病控制的强大能力非常重要。